{
    "2020-06-30": [
        [
            {
                "time": "",
                "original_text": "A股年中盘点：医药领跑市场，超90%主动基金获正收益",
                "features": {
                    "keywords": [
                        "医药",
                        "主动基金",
                        "正收益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【天风医药】圣湘生物：分子诊断筛查龙头，2020扬帆起航",
                "features": {
                    "keywords": [
                        "圣湘生物",
                        "分子诊断",
                        "龙头"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-02",
                "original_text": "君实生物确定发行价55.74元/股 将于7月2日网上申购",
                "features": {
                    "keywords": [
                        "君实生物",
                        "发行价",
                        "网上申购"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“吃药”半年业绩暴增逾70%! 冠亚军基金经理独家透露“擒牛”秘诀",
                "features": {
                    "keywords": [
                        "吃药",
                        "业绩暴增",
                        "基金经理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-30",
                "original_text": "6月30日晚间上市公司十大重磅公告",
                "features": {
                    "keywords": [
                        "上市公司",
                        "重磅公告"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "百济神州上半年成绩：PD-1单抗3.5个亿、合作收入归0，重金投入研发",
                "features": {
                    "keywords": [
                        "百济神州",
                        "PD-1单抗",
                        "研发"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "基金“中考”成绩出炉,首尾业绩相差超90%! 排名前十全部为医药类基金，净值平均上涨超过65%",
                "features": {
                    "keywords": [
                        "基金",
                        "医药类基金",
                        "净值上涨"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "56股主力资金净流入超亿元",
                "features": {
                    "keywords": [
                        "主力资金",
                        "净流入"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "司太立(603520)：碘海醇制剂获批 未来增长可期",
                "features": {
                    "keywords": [
                        "司太立",
                        "碘海醇制剂",
                        "获批"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "揭秘送转股206只除权以来股价上涨",
                "features": {
                    "keywords": [
                        "送转股",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药(600276.SH)获一项药品注册批件",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "药品注册",
                        "批件"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "基金半年度冠军今天出炉：医药基金霸屏 最高回报达80%",
                "features": {
                    "keywords": [
                        "基金",
                        "医药基金",
                        "最高回报"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "农银汇理创新医疗混合基金最新净值涨幅达2.10％",
                "features": {
                    "keywords": [
                        "农银汇理",
                        "创新医疗",
                        "净值涨幅"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北上资金小幅流出 该股或从底部启动",
                "features": {
                    "keywords": [
                        "北上资金",
                        "流出",
                        "底部启动"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "CXO泡沫浴：分享创新药红利的最好方式",
                "features": {
                    "keywords": [
                        "CXO",
                        "创新药",
                        "红利"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-29",
                "original_text": "A股融资融券日报：两融余额增加86.23亿元（6月29日）",
                "features": {
                    "keywords": [
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}